An open source pharma roadmap

In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.

Saved in:
Bibliographic Details
Published in:PLoS medicine 2017-04, Vol.14 (4), p.e1002276-e1002276
Main Authors: Balasegaram, Manica, Kolb, Peter, McKew, John, Menon, Jaykumar, Olliaro, Piero, Sablinski, Tomasz, Thomas, Zakir, Todd, Matthew H, Torreele, Els, Wilbanks, John
Format: Article
Language:English
Subjects:
Abbreviations
African trypanosomiasis
Alzheimer's disease
Analysis
Antimicrobial resistance
Artesunate
Business law
Cancer
Clinical trials
Commercialization
Community participation
Competition
Competitive Behavior
Computer and Information Sciences
Consumer Advocacy - standards
Data processing
Drug development
Drug discovery
Drug Discovery - economics
Drug Discovery - methods
Drug Discovery - organization & administration
Drug Industry - economics
Drug Industry - methods
Drug Industry - organization & administration
Health risks
Humans
India
Innovations
Life sciences
Malaria
Medicine and Health Sciences
Models, Theoretical
Neurodegenerative diseases
Nitroimidazole
Open source software
Organizations, Nonprofit
Pharmaceutical industry
Pharmaceutical Preparations - supply & distribution
Product development
Public health
R&D
Rectum
Research & development
Research - economics
Research - organization & administration
Reviews
Risk assessment
Science Policy
Social Sciences
Software
Specialization
Translation
Tropical diseases
Tuberculosis
Visceral leishmaniasis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.1002276